Abnormal constitutive NF-κB activation is widely found in diverse types of hematopoietic malignancies (e.g. CML [12], acute myeloid leukemia [13], Hodgkin's disease [14]) as well as solid tumors. Here, NFKB1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.